Clinical Trials
7 trialsNCT01638546 2026-04-29
Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04919382 2026-04-08
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
Big Ten Cancer Research Consortium
Phase 2 Recruiting
NCT03728361 2025-12-18
Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT03672773 2025-11-10
TRIO-US L-07
Jonsson Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT02605811 2019-03-28
Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer
Guangzhou Medical University
Phase 2 Unknown
NCT01900951 2016-01-26
Temozolomide as Maintenance Therapy in Small Cell Lung Cancer
Chinese PLA General Hospital
Phase 2 Unknown
NCT00022711 2013-07-11
Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer
Fox Chase Cancer Center
Phase 2 Completed